Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Department of Pathology and Laboratory Medicine, |
RCV001357061 | SCV001552394 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The PKD1 p.Gly2428Gly variant was not identified in the literature nor was it identified in ClinVar, LOVD 3.0 or the ADPKD Mutation Database. The variant was identified in dbSNP (ID: rs1177672366) and in control databases in 3 of 234918 chromosomes at a frequency of 0.000013 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: East Asian in 1 of 17764 chromosomes (freq: 0.000056), South Asian in 1 of 30330 chromosomes (freq: 0.000033), European (non-Finnish) in 1 of 108792 chromosomes (freq: 0.000009); it was not observed in the African, Latino, Ashkenazi Jewish, European (Finnish), and Other populations. In addition we cannot be certain that data from control databases is specific to PKD1 and not from one of the six PKD1 pseudogenes. The p.Gly2428Gly variant is not expected to have clinical significance because it does not result in a change of amino acid and is not located in a known consensus splice site. The variant occurs outside of the splicing consensus sequence however 3 of 4 in silico or computational prediction software programs (MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing and the creation of a new 5' splice site. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |